Cargando…
PD-L1/miR-155 Interplay in Pediatric High-Grade Glioma
High-grade pediatric glioma (p-HGG—WHO 2021, formerly GBM—WHO 2016), as a common, aggressive, and highly lethal primary brain malignancy in adults, accounts for only 3–15% of primary brain tumors in pediatric patients. After leukemia, brain malignancies are the second most common in the pediatric po...
Autores principales: | Litak, Jakub, Grajkowska, Wiesława, Bogucki, Jacek, Kowalczyk, Paweł, Petniak, Alicja, Podkowiński, Arkadiusz, Szumiło, Justyna, Kocki, Janusz, Roliński, Jacek, Rahnama-Hezavah, Mansur, Roszkowski, Marcin, Grochowski, Cezary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946275/ https://www.ncbi.nlm.nih.gov/pubmed/35326280 http://dx.doi.org/10.3390/brainsci12030324 |
Ejemplares similares
-
PD-L1 Expression Correlated with p53 Expression in Pediatric Glioblastoma Multiforme
por: Litak, Jakub, et al.
Publicado: (2021) -
Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme
por: Mazurek, Marek, et al.
Publicado: (2020) -
Hydroxyapatite Use in Spine Surgery—Molecular and Clinical Aspect
por: Litak, Jakub, et al.
Publicado: (2022) -
TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme—Future Perspectives
por: Litak, Jakub, et al.
Publicado: (2020) -
New Horizons for Hydroxyapatite Supported by DXA Assessment—A Preliminary Study
por: Litak, Jakub, et al.
Publicado: (2022)